Business Description
SomnoMed Ltd
SIC : 3840
ISIN : AU000000SOM1
Description
SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, Som Tabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.41 | |||||
| Equity-to-Asset | 0.65 | |||||
| Debt-to-Equity | 0.15 | |||||
| Debt-to-EBITDA | -2.56 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.19 | |||||
| Beneish M-Score | -2.84 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8.6 | |||||
| 3-Year EPS without NRI Growth Rate | -116.2 | |||||
| 3-Year FCF Growth Rate | -95.4 | |||||
| 3-Year Book Growth Rate | -11.2 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 10.31 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 4.61 | |||||
| 9-Day RSI | 6.98 | |||||
| 14-Day RSI | 12.94 | |||||
| 3-1 Month Momentum % | -10.08 | |||||
| 6-1 Month Momentum % | -3.6 | |||||
| 12-1 Month Momentum % | -54.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.76 | |||||
| Quick Ratio | 1.45 | |||||
| Cash Ratio | 0.81 | |||||
| Days Inventory | 50.68 | |||||
| Days Sales Outstanding | 34.98 | |||||
| Days Payable | 121.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -25.9 | |||||
| Shareholder Yield % | -26.48 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 60.15 | |||||
| Operating Margin % | -9.09 | |||||
| Net Margin % | -13.36 | |||||
| FCF Margin % | -12.75 | |||||
| ROE % | -37.73 | |||||
| ROA % | -18.72 | |||||
| ROIC % | -22.2 | |||||
| 3-Year ROIIC % | -56.94 | |||||
| ROC (Joel Greenblatt) % | -64.37 | |||||
| ROCE % | -17.95 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.63 | |||||
| PB Ratio | 2.26 | |||||
| Price-to-Tangible-Book | 4.1 | |||||
| EV-to-EBIT | -11.22 | |||||
| EV-to-EBITDA | -35.87 | |||||
| EV-to-Revenue | 1.03 | |||||
| EV-to-FCF | -8.08 | |||||
| Price-to-GF-Value | 0.2 | |||||
| Price-to-Median-PS-Value | 0.25 | |||||
| Price-to-Net-Current-Asset-Value | 9.6 | |||||
| Earnings Yield (Greenblatt) % | -8.91 | |||||
| FCF Yield % | -11.25 | |||||
| Forward Rate of Return (Yacktman) % | 7.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SOMNF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SomnoMed Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 61.098 | ||
| EPS (TTM) ($) | -0.067 | ||
| Beta | 0.94 | ||
| 3-Year Sharpe Ratio | -0.84 | ||
| 3-Year Sortino Ratio | -1.11 | ||
| Volatility % | 110.04 | ||
| 14-Day RSI | 12.94 | ||
| 14-Day ATR ($) | 0.001716 | ||
| 20-Day SMA ($) | 0.16906 | ||
| 12-1 Month Momentum % | -54.91 | ||
| 52-Week Range ($) | 0.13 - 0.3857 | ||
| Shares Outstanding (Mil) | 216.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SomnoMed Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SomnoMed Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
SomnoMed Ltd Frequently Asked Questions
What is SomnoMed Ltd(SOMNF)'s stock price today?
The current price of SOMNF is $0.17. The 52 week high of SOMNF is $0.39 and 52 week low is $0.13.
When is next earnings date of SomnoMed Ltd(SOMNF)?
The next earnings date of SomnoMed Ltd(SOMNF) is .
Does SomnoMed Ltd(SOMNF) pay dividends? If so, how much?
SomnoMed Ltd(SOMNF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers